Cartesian Therapeutics, Inc. (RNAC)

NASDAQ: RNAC · IEX Real-Time Price · USD

16.16

-0.53 (-3.18%)

At close: Jul 19, 2024, 4:00 PM

16.50

+0.34 (2.10%)

Pre-market: Jul 22, 2024, 8:32 AM EDT

Cartesian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Market Capitalization	345	107	173	380	327	115	Upgrade
Market Cap Growth	-50.61%	-38.12%	-54.53%	16.17%	185.36%	92.22%	Upgrade
Enterprise Value	253	41	76	288	224	44	Upgrade
PE Ratio	-	-0.49	4.89	-14.80	-4.75	-2.07	Upgrade
PS Ratio	13.34	4.12	1.56	4.47	19.72	17.18	Upgrade
PB Ratio	-0.90	-0.24	1.84	16.89	-18.18	13.66	Upgrade
P/FCF Ratio	-1.78	-2.08	-5.27	-6.19	9.59	-2.23	Upgrade
P/OCF Ratio	-1.81	-2.09	-5.47	-6.30	9.38	-2.23	Upgrade
EV/Sales Ratio	9.75	1.58	0.69	3.38	13.50	6.56	Upgrade
EV/EBITDA Ratio	-0.05	-0.18	1.89	-63.80	-3.42	-0.85	Upgrade
EV/EBIT Ratio	-0.05	-0.17	2.02	-41.81	-3.33	-0.81	Upgrade
EV/FCF Ratio	-0.21	-0.80	-2.32	-4.68	6.56	-0.85	Upgrade
Debt / Equity Ratio	-0.09	-0.02	0.40	1.57	-1.96	2.30	Upgrade
Debt / EBITDA Ratio	-0.04	-0.05	0.94	-7.83	-0.54	-0.37	Upgrade
Debt / FCF Ratio	-0.18	-0.21	-1.16	-0.57	1.04	-0.38	Upgrade
Quick Ratio	2.94	1.26	5.76	1.91	1.79	2.72	Upgrade
Current Ratio	3.03	1.33	5.91	2.00	1.86	2.77	Upgrade
Asset Turnover	0.12	0.15	0.65	0.50	0.13	0.11	Upgrade
Interest Coverage	-134.24	-83.26	12.47	-2.42	-43.26	-35.44	Upgrade
Return on Equity (ROE)	236.40%	366.40%	43.70%	513.70%	583.70%	-1206.10%	Upgrade
Return on Assets (ROA)	-116.40%	-124.40%	20.90%	-15.00%	-54.00%	-89.10%	Upgrade
Return on Capital (ROIC)	76.53%	20.13%	11.23%	-7.95%	-327.65%	-189.55%	Upgrade
Earnings Yield	-73.77%	-205.34%	20.46%	-6.75%	-21.04%	-48.25%	Upgrade
FCF Yield	-17.07%	-48.01%	-18.99%	-16.16%	10.43%	-44.77%	Upgrade
Buyback Yield / Dilution	-5.92%	-6.33%	-27.59%	-12.97%	-122.19%	-103.44%	Upgrade
Total Shareholder Return	-5.92%	-6.33%	-27.59%	-12.97%	-122.19%	-103.44%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).